GRP - gastrin releasing peptide Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 102166444
GRP Products (2)
| mRNA | Protein | Name |
|---|---|---|
| XM_021075302.1 | XP_020930961.1 | gastrin-releasing peptide isoform X1 |
| XM_021075305.1 | XP_020930964.1 | gastrin-releasing peptide isoform X2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
gastrin-releasing peptide |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-10210 | Retaspimycin Hydrochloride | Inhibitor | 95.49% | Phase 3 |
| HY-15263 | Retaspimycin | Inhibitor | / | Phase 3 |
| HY-147039 | BOLD-100 free base | / | Phase 2 | |
| HY-15785 | Pimitespib | Inhibitor | 99.87% | Phase 1 |
| HY-15190 | NVP-HSP990 | 99.49% | Phase 1 | |
| HY-P0039 | BIM-26226 | Antagonist | 98.73% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(110)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-N0830 | Palmitic acid | Activator | 99.86% | Unkown |
| HY-10941 | VER-155008 | Inhibitor | 99.82% | Unkown |
| HY-N0830B | Palmitic acid sodium | Activator | 95.0% | Unkown |
| HY-N0830S6 | Palmitic acid-13C16 | Activator | 99.72% | Unkown |
| HY-100437 | HA15 | 99.98% | Unkown | |
| HY-110188 | BiP inducer X | Inhibitor | 99.62% | Unkown |
| HY-18680 | PU-WS13 | Inhibitor | 99.88% | Unkown |
| HY-P0238 | Gastrin-Releasing Peptide, human | 99.41% | Unkown | |
| HY-N0830S2 | Palmitic acid-d31 | Activator | 99.56% | Unkown |
| HY-P0221C | PACAP (1-38) free acid | 99.94% | Unkown | |
| HY-W250122 | Glutamic acid sodium salt | 99.92% | Unkown | |
| HY-10214 | SNX-2112 | 99.49% | Unkown | |
| HY-138364 | YUM70 | 98.01% | Unkown | |
| HY-N0830R | Palmitic acid (Standard) | Activator | 98.31% | Unkown |
| HY-N0830S9 | Palmitic acid-13C | Activator | 98.0% | Unkown |
| HY-112910 | Grp94 Inhibitor-1 | Inhibitor | 98.75% | Unkown |
| HY-132182 | HPA-12 | 99.40% | Unkown | |
| HY-125974 | HM03 | Inhibitor | 99.51% | Unkown |
| HY-N0830BS1 | Palmitic acid-13C16 sodium | Activator | 99.1% | Unkown |
| HY-N0830S5 | Palmitic acid-d3 | Activator | 99.80% | Unkown |
| HY-10942 | VER-82576 | Inhibitor | 98.76% | Unkown |
| HY-N2122 | Neoisoliquiritin | 99.74% | Unkown | |
| HY-155417 | GPR34 receptor antagonist 3 | 99.88% | Unkown | |
| HY-162774A | GRP75-IN-1 dihydrochloride | Inducer | 99.75% | Unkown |
| HY-W020952 | Palladium(Ⅱ) acetylacetonate | 98.2% | Unkown | |
| HY-N0830S4 | Palmitic acid-d2 | Activator | 99.8% | Unkown |
| HY-N0830S3 | Palmitic acid-1-13C | Activator | 98.0% | Unkown |
| HY-N8439 | Questiomycin A | 99.00% | Unkown | |
| HY-50670 | DGAT-1 inhibitor 2 | 95.33% | Unkown | |
| HY-152153 | GRP78-IN-3 | Inhibitor | 99.88% | Unkown |
| HY-N0830S7 | Palmitic acid-d4 | Activator | 99.88% | Unkown |
| HY-129692 | Withanone | Inhibitor | 93.28% | Unkown |
| HY-N0830S10 | Palmitic acid-13C2 | Activator | 99.54% | Unkown |
| HY-103544 | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P | 98.48% | Unkown | |
| HY-117395 | PU-H54 | Inhibitor | 99.04% | Unkown |
| HY-155063 | TRAP1-IN-1 | Inhibitor | 96.03% | Unkown |
| HY-N2600 | Kuwanon H | Antagonist | 98.60% | Unkown |
| HY-103277A | BIM 23042 TFA | Antagonist | 99.75% | Unkown |
| HY-N0830S12 | Palmitic acid-d4-1 | Activator | 99.80% | Unkown |
| HY-N0830S18 | Palmitic acid-d1 | Activator | 99.90% | Unkown |
| HY-N0830S | Palmitic acid-1,2,3,4-13C4 | Activator | 99.9% | Unkown |
| HY-P3112 | ICI 216140 | Antagonist | 99.78% | Unkown |
| HY-133735A | GRP-60367 hydrochloride | Inhibitor | 99.41% | Unkown |
| HY-103283 | Neuromedin C (porcine) | 98.29% | Unkown | |
| HY-P1185 | Antagonist G | 99.05% | Unkown | |
| HY-P3576A | Biotin-Gastrin Releasing Peptide, human TFA | / | Unkown | |
| HY-121845 | 4-Br-Bnlm | Inhibitor | 99.46% | Unkown |
| HY-162767 | KUNG65 | Inhibitor | 98.84% | Unkown |
| HY-44154 | PSB-CB5 | 98.3% | Unkown | |
| HY-N0830BS | Palmitic acid-13C sodium | Activator | 98.0% | Unkown |
| HY-N0830S20 | Palmitic acid-d9 | Activator | / | Unkown |
| HY-P10055 | PSMA targeting peptide | / | Unkown | |
| HY-W134007S1 | Hexadecanoate-13C16 potassium | Activator | 98.40% | Unkown |
| HY-P10055A | PSMA targeting peptide TFA | 99.09% | Unkown | |
| HY-119732 | KUNG94 | Inhibitor | / | Unkown |
| HY-103063 | Iso-PU-H54 | Inhibitor | / | Unkown |
| HY-103277 | BIM 23042 | Antagonist | / | Unkown |
| HY-103285 | GRP (porcine) | Activator | / | Unkown |
| HY-120800 | KUNG29 | Inhibitor | / | Unkown |
| HY-121723 | PU-H39 | Inhibitor | / | Unkown |
| HY-124221 | Radamide | / | Unkown | |
| HY-125974A | HM03 trihydrochloride | Inhibitor | / | Unkown |
| HY-145504 | 12-Dipalmitoyl-3-Linoelaidoyl-rac-glycerol | / | Unkown | |
| HY-145540 | 1,2-Dipalmitoyl-3-Octanoyl-rac-glycerol | / | Unkown | |
| HY-145857 | GRP78-IN-1 | / | Unkown | |
| HY-146420 | GRP78-IN-2 | Inhibitor | / | Unkown |
| HY-162768 | Grp94 Inhibitor-2 | Inhibitor | / | Unkown |
| HY-162774 | GRP75-IN-1 | Inducer | / | Unkown |
| HY-170818 | Grp94 Inhibitor-3 | Inhibitor | / | Unkown |
| HY-171992 | COX-2-IN-55 | 99.20% | Unkown | |
| HY-175042 | D-myo-Inositol-1,3,4,5,6-pentaphosphate ammonium salt | Inhibitor | 98% | Unkown |
| HY-175865 | HSP70-IN-7 | / | Unkown | |
| HY-17674 | Bombesin receptor antagonist-1 | Antagonist | / | Unkown |
| HY-180195 | Grp94-IN-3 | Inhibitor | / | Unkown |
| HY-182360 | Cytisine-platinum(IV) prodrug-1 | / | Unkown | |
| HY-D2334 | AlF-NOTA-c-d-VAP | / | Unkown | |
| HY-N0830A | Palmitic acid calcium | Activator | / | Unkown |
| HY-N0830BS4 | Palmitic acid-13C8 sodium | Activator | / | Unkown |
| HY-N0830S1 | Palmitic acid-15,15,16,16,16-d5 | Activator | / | Unkown |
| HY-N0830S11 | Palmitic acid-d2-1 | Activator | / | Unkown |
| HY-N0830S13 | Palmitic acid-d4-2 | Activator | / | Unkown |
| HY-N0830S14 | Palmitic acid-d17 | Activator | / | Unkown |
| HY-N0830S15 | Palmitic acid-d2-2 | Activator | / | Unkown |
| HY-N0830S16 | Palmitic acid-d2-3 | Activator | / | Unkown |
| HY-N0830S17 | Palmitic acid-d2-4 | Activator | / | Unkown |
| HY-N0830S19 | Palmitic acid-d2-5 | Activator | / | Unkown |
| HY-N0830S21 | Palmitic acid-d5 | Activator | / | Unkown |
| HY-N0830S8 | Palmitic acid-9,10-d2 | Activator | / | Unkown |
| HY-N12656 | Versipelostatin | Inhibitor | / | Unkown |
| HY-P0221B | PACAP (1-38) free acid TFA | / | Unkown | |
| HY-P11031 | CotH3 peptide | Inhibitor | / | Unkown |
| HY-P11769 | RM2 | Antagonist | / | Unkown |
| HY-P1185A | Antagonist G TFA | / | Unkown | |
| HY-P3084 | Human follicular gonadotropin releasing peptide | / | Unkown | |
| HY-P3576 | Biotin-Gastrin Releasing Peptide, human | / | Unkown | |
| HY-P4689 | Prolactin-Releasing Peptide (1-31) (rat) | Activator | / | Unkown |
| HY-P5072 | GRP (14-27) (human, porcine, canine) | Agonist | / | Unkown |
| HY-RS05844 | GRP Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS07612 | LGALSL Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS07859 | LSM4 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS15406 | UCMA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W127458 | Tin(II) palmitate | Activator | / | Unkown |
| HY-W851050A | BAP2 | Inhibitor | / | Unkown |
| HY-121459 | Neoantimycin | Modulator | / | Unkown |
| HY-133735 | GRP-60367 | Inhibitor | 98.23% | Unkown |
| HY-N0830S22 | Palmitic acid-13C-1 | / | Unkown | |
| HY-RS16891 | Grp Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS19968 | Ucma Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23333 | Grp Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26471 | Ucma Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990805 | Anti-Human/Mouse GRP78 Antibody (C38) | Inhibitor | 95.00% | Unkown |
| HY-P990239 | Anti-Human/Mouse GRP78 Antibody (N88) | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service